Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuko Shirota
Yuko Shirota
National Institutes of Health
Immunology
Medicine
B-1 cell
CD40
Internal medicine
5
Papers
1020
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus
2013
Annals of the Rheumatic Diseases
Yuko Shirota
Cheryl Yarboro
Randy T. Fischer
Tuyet-Hang Pham
Peter E. Lipsky
Gabor G. Illei
Show All
Source
Cite
Save
Citations (102)
Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation study
2010
Arthritis & Rheumatism
Gabor G. Illei
Yuko Shirota
Cheryl Yarboro
Jimmy Daruwalla
Edward Tackey
Kazuki Takada
Thomas A. Fleisher
James E. Balow
Peter E. Lipsky
Show All
Source
Cite
Save
Citations (420)
with Sjögren's syndrome type 3 autoantibodies in serum from patients specific enough to detect muscarinic receptor Peptide-based ELISAs are not sensitive and
2010
Nienke Roescher
A. Kingman
Yuko Shirota
Show All
Source
Cite
Save
Citations (0)
Identification and characterization of circulating human transitional B cells
2005
Blood
Gary P. Sims
Rachel Ettinger
Yuko Shirota
Cheryl Yarboro
Gabor G. Illei
Peter E. Lipsky
Show All
Source
Cite
Save
Citations (475)
1